19 reports

The company is also carrying out trials for Praluent®, a biopharmaceutical anti-cholesterol drug (a human monoclonal antibody) used to treat high cholesterol in adults whose cholesterol is not controlled by diet and statin treatment.

  • Cardiovascular Drug
  • World
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • CARDIOVASCULAR DRUGS

For example, Ustekinumab (Stelara), a Janssen Biotech brand, is a human monoclonal antibody used for the treatment of plaque psoriasis in the USA, Canada and Europe.

  • Cardiovascular Drug
  • Market Size
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.

One such trend is the emergence of biomarkers.

  • Cardiovascular Drug
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.

Biopharmaceuticals such as monoclonal antibodies are different from small molecule drugs because of their biological nature.

  • Cardiovascular Drug
  • China
  • Demand
  • Forecast
  • Market Size
  • EARLY-STAGE PIPELINE PRODUCTS FOR AF - ANTICOAGULANT AGENTS

US KEY OPINION LEADER US KEY OPINION LEADER Pipeline Assessment THE SECOND CLINICALLY MOTIVATED DISCONTINUATION WAS IN 2012 BY THROMBOGENICS AND BIOINVENT INTERNATIONAL, WHICH TERMINATED THE DEVELOPMENT OF TB-##, A RECOMBINANT HUMAN MONOCLONAL ANTIBODY THAT TARGETS AND INHIBITS FA

  • Cardiovascular Drug
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Daiichi Sankyo Company
  • Pfizer Inc.
  • ANTI-HYPERTENSIVE THERAPEUTICS MARKET, GLOBAL, ALL PIPELINE PRODUCTS, PRECLINICAL,
  • 5.4 Competitive Clinical Trials Metrics Analysis

Monoclonal antibodies (mAb) account for two of the biologic molecules, and there is one stem cell therapies, one antisense oligonucleotide and one oligonucleotide.

  • Cardiovascular Drug
  • Market Size
  • Daiichi Sankyo Company
  • Merck & Co., Inc.
  • Novartis AG
  • R&D Progress Research and Development Brief
  • PT-199 - DRUG PROFILE

Monoclonal antibody acts by inhibiting CD##.

  • Cardiovascular Drug
  • Medical Biotechnology
  • United States
  • Company Operations
  • Product Initiative
  • OLECLUMAB - DRUG PROFILE
  • R&D Progress Research and Development Brief

IT IS A MONOCLONAL ANTIBODY TARGETING CD##.

  • Cardiovascular Drug
  • Medical Biotechnology
  • United States
  • World
  • Product Initiative

Pasteur Institute NA NA MONOCLONAL ANTIBODY TO ANTAGONIZE FCGRIIA FOR AUTOIMMUNE ARTHRITIS, PULMONARY INFLAMMATION, SYSTEMIC ANAPHYLAXIS AND THROMBOCYTOPENIA - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description

  • Cardiovascular Drug
  • Therapy
  • United States
  • World
  • Product Initiative

Pasteur Institute NA NA MONOCLONAL ANTIBODY TO ANTAGONIZE FCGRIIA FOR AUTOIMMUNE ARTHRITIS, PULMONARY INFLAMMATION, SYSTEMIC ANAPHYLAXIS AND THROMBOCYTOPENIA - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description

  • Cardiovascular Drug
  • Therapy
  • United States
  • World
  • Product Initiative
  • OLECLUMAB - DRUG PROFILE
  • BRISTOL-MYERS SQUIBB CO

IT IS A MONOCLONAL ANTIBODY TARGETING CD##.

  • Cardiovascular Drug
  • Oncology
  • Pharmaceutical
  • United States
  • Product Initiative

IT IS A FULLY HUMAN MONOCLONAL ANTIBODY THAT ACTS BY TARGETING P-SELECTIN GLYCOPROTEIN LIGAND-## (PSGL-##).

  • Cardiovascular Drug
  • Hospital
  • Pharmaceutical
  • United States
  • Product Initiative

Cardiovascular and Metabolic Diseases Respiratory ## ##. ##. ## P R O D U C T S O F F E R E D Category ANGIOTENSIN II ANTAGONIST BETA-BLOCKER CALCIUM ANTAGONIST Source: Annual Report, Press Releases ## ##. ##. ## S W O T A N A L Y S I S ATACAND ATACAND HCT TENORMIN SELOKEN ZOK/ TOP

  • Cardiovascular Drug
  • North America
  • United States
  • World
  • Forecast
  • MONOCLONAL ANTIBODY TO INHIBIT CD73 FOR ONCOLOGY - DRUG PROFILE
  • Mechanism Of Action

Monoclonal antibody is a CD## inhibitor.

  • Cardiovascular Drug
  • Oncology
  • United States
  • World
  • Product Initiative

## ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## ## Canada ## ## ## ## ## ## ## ## ## United Kingdom Source: Glob

  • Acute Coronary Syndrome
  • Cardiovascular Disease
  • Cardiovascular Drug
  • Clinical Trial
  • AstraZeneca PLC
  • MONOCLONAL ANTIBODY TO INHIBIT CD73 FOR ONCOLOGY - DRUG PROFILE
  • R&D Progress Research and Development Brief

Monoclonal antibody is a CD## inhibitor.

  • Cardiovascular Drug
  • Therapy
  • United States
  • World
  • Product Initiative

These drugs are synthesized with the use of biologic components such as monoclonal antibodies, proteins, hormones, nucleic acids, colony stimulating factors, interleukins, and enzymes.

  • Anti-Infective
  • Cardiovascular Drug
  • Japan
  • Meiji Seika Pharma Co., Ltd.
  • Nipro Corporation
  • ID No. Name

Name Product Target / Mechanism of Action Class of Compound Rec monoclonal antibody Rec human monoclonal antibody Rec humanized monoclonal antibody Bristol-Myers Squibb (BMS) MedImmune (AstraZeneca) Innate Pharma Company Product Category

  • Cardiovascular Drug
  • Therapy
  • Compugen Ltd.

As a result, both the number and diversity of molecule types now commonly found in developmental pipelines have increased substantially, and are expected to continue to grow - particularly monoclonal Antibodies (mAbs), proteins, peptides, and vaccines.

  • Cardiovascular Drug
  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Therapy